August 5, 2021 Environ, Ag./Food & Bev PAI Top-10

BD Announces Third Fiscal Quarter Results; Strong Base Growth Drives Better Performance In Quarter And Higher Guidance For Fiscal 2021

FRANKLIN LAKES, N.J., Aug. 5, 2021 /PRNewswire/ — Third fiscal quarter revenues of $4.9 billion grew 26.9% on a reported basis. On a currency-neutral basis, revenues increased 22.0%. BD’s COVID-19 testing revenues were $300 million, including BD Veritor™ Plus System revenues of $212 million. Third fiscal quarter GAAP diluted earnings per share (EPS) increased 77.3%... Read more

August 3, 2021 PAI Top-10 PR/Corporate

Xylem Reports Second Quarter 2021 Results

29% organic orders growth on broad underlying demand across segments Revenue growth 16% on a reported basis, 11% organically Adjusted EBITDA margin of 17.3%, up 200 basis points; net income as a percentage of revenue of 8.4%, up 570 basis points Reported net income of $113 million or $0.62 per share; adjusted net income of... Read more

August 2, 2021 Lab Top-10 PAI Top-10 PR/Corporate

Bruker Reports Second Quarter 2021 Financial Results

Q2 2021 revenue growth of 34.4% year-over-year; organic revenue growth of 27.2% Q2 2021 GAAP EPS of $0.38; non-GAAP EPS of $0.44, compared to $0.21 in Q2 2020 Strong financial performance in the Bruker Scientific Instruments and BEST businesses drives a further increase in fiscal year 2021 guidance BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR)... Read more

July 26, 2021 Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 PR/Corporate

PerkinElmer Announces Financial Results for the Second Quarter of 2021

Revenue of $1.228 billion; 51% reported growth; 41% organic growth GAAP EPS from continuing operations of $2.19; Adjusted EPS of $2.83 Initiates Third Quarter and Raises Full-Year Revenue and Earnings Guidance Announces Agreement to Acquire BioLegend – Leading Antibody & Research Reagent Provider Earnings Call Moved to Today at 8:00 a.m. Eastern Time; Dial-in Information... Read more

July 26, 2021 Lab Top-10 Liq. Handling & Robotics PAI Top-10

PerkinElmer to Acquire Antibody and Reagent Leader BioLegend

Transformative deal significantly scales leading position in life science to accelerate legendary discoveries in precision medicine Leader in antibody development with highly complementary, innovative portfolio in emerging, high-growth areas of biologics, cell and gene therapy, proteogenomics, and recombinant proteins Commercial synergy opportunity to accelerate life science growth with potential benefits for diagnostics franchise Annual BioLegend... Read more

July 22, 2021 Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 PR/Corporate

Danaher Reports Second Quarter 2021 Results

WASHINGTON, July 22, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the second quarter 2021.  All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended July 2, 2021, net earnings were $1.7 billion, or $2.28 per diluted common share which represents an 84.0% year-over-year... Read more

July 21, 2021 Acad, Gov/Utilities Other Lab Products/Services PAI Top-10

FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine for the treatment of patients with myelodysplastic syndromes

Every year in the US, approximately 10,000 people are diagnosed with myelodysplastic syndromes (MDS), and there remains a high unmet need for new treatment options1 The designation is based on interim results from the phase Ib M15-531 study investigating Venclexta/Venclyxto plus azacitidine in people with previously untreated higher-risk MDS This is the 11th Breakthrough Therapy... Read more

July 19, 2021 Molecular Spectroscopy PAI Top-10

WITec and attocube launch cryoRaman

Technology leaders combine expertise for very low-temperature Raman imaging Ulm, Germany – Haar, Germany July 20, 2021 Raman imaging innovator WITec GmbH and cryogenic microscopy specialist attocube systems AG have jointly introduced cryoRaman. This cryogenic Raman imaging system integrates attocube’s leading-edge cryostat and nanopositioner technology with the vaunted sensitivity and modularity of WITec’s alpha300 correlative... Read more

July 19, 2021 PAI Top-10 Product Launch

New data for Roche’s Hemlibra reinforce safety profile in people with haemophilia A

Final analysis from the phase IIIb STASEY study, including data from 193 people with haemophilia A, further support the benefit/risk profile of Hemlibra, with no new safety signals identified1 STASEY is one of the largest open-label studies primarily assessing safety and tolerability of a medicine for people with haemophilia A with factor VIII inhibitors Hemlibra... Read more